Mikael Åberg

1.6k total citations
40 papers, 577 citations indexed

About

Mikael Åberg is a scholar working on Infectious Diseases, Hematology and Molecular Biology. According to data from OpenAlex, Mikael Åberg has authored 40 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Mikael Åberg's work include SARS-CoV-2 and COVID-19 Research (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and COVID-19 Clinical Research Studies (6 papers). Mikael Åberg is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and COVID-19 Clinical Research Studies (6 papers). Mikael Åberg collaborates with scholars based in Sweden, United States and Austria. Mikael Åberg's co-authors include Agneta Siegbahn, Agneta Siegbahn, Malin Wickström, Matilda Johnell, Teet Velling, Lars Wallentin, Christina Christersson, Emil Hagström, Tanja B. Grammer and Erik Björklund and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mikael Åberg

34 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikael Åberg Sweden 14 174 113 102 101 99 40 577
Sebastiano Cicco Italy 13 209 1.2× 140 1.2× 55 0.5× 63 0.6× 190 1.9× 52 718
Emilie Montenont United States 10 98 0.6× 95 0.8× 77 0.8× 31 0.3× 106 1.1× 15 438
Michael Bernimoulin Switzerland 13 336 1.9× 156 1.4× 43 0.4× 133 1.3× 180 1.8× 17 714
Monica D. Traystman United States 12 191 1.1× 152 1.3× 180 1.8× 87 0.9× 98 1.0× 15 615
Samir Saheb France 16 175 1.0× 72 0.6× 155 1.5× 83 0.8× 120 1.2× 48 826
Francisco Vidal Spain 19 440 2.5× 287 2.5× 77 0.8× 177 1.8× 179 1.8× 60 985
Noriyuki Hiramatsu Japan 9 256 1.5× 77 0.7× 39 0.4× 85 0.8× 371 3.7× 15 870
Debjit Biswas United States 8 179 1.0× 220 1.9× 46 0.5× 60 0.6× 414 4.2× 12 777
Baohua Qian China 14 217 1.2× 74 0.7× 39 0.4× 105 1.0× 173 1.7× 25 558
Vesna Brglez France 18 188 1.1× 47 0.4× 19 0.2× 96 1.0× 158 1.6× 43 815

Countries citing papers authored by Mikael Åberg

Since Specialization
Citations

This map shows the geographic impact of Mikael Åberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Åberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Åberg more than expected).

Fields of papers citing papers by Mikael Åberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikael Åberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Åberg. The network helps show where Mikael Åberg may publish in the future.

Co-authorship network of co-authors of Mikael Åberg

This figure shows the co-authorship network connecting the top 25 collaborators of Mikael Åberg. A scholar is included among the top collaborators of Mikael Åberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael Åberg. Mikael Åberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Åberg, Mikael, Håkan Åhlström, Paul Hockings, et al.. (2025). Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study. Scandinavian Journal of Gastroenterology. 60(6). 597–605.
2.
Babačić, Haris, Xiaofang Cao, Jenny Forshed, et al.. (2025). Comparative evaluation of Olink Explore 3072 and mass spectrometry with peptide fractionation for plasma proteomics. Communications Chemistry. 8(1). 327–327.
3.
Eriksson, Mats, Michael Hultström, Mikael Åberg, et al.. (2025). Mapping Interactions Between Cytokines, Chemokines, Growth Factors, and Conventional Biomarkers in COVID-19 ICU-Patients. International Journal of Molecular Sciences. 26(23). 11419–11419.
4.
Wang, Mengqi, Masood Kamali‐Moghaddam, Liza Löf, et al.. (2024). Monitoring SARS-CoV-2 IgA, IgM and IgG antibodies in dried blood and saliva samples using antibody proximity extension assays (AbPEA). Scientific Reports. 14(1). 21655–21655.
5.
Hjalmar, Viktoria, Henry Ng, Fay Probert, et al.. (2024). Plasma H3Cit-DNA Discriminates Between Cancer and Inflammation in a Cohort of Patients with Unspecific Cancer Symptoms. Inflammation. 48(2). 760–769. 4 indexed citations
6.
Aguilera, Katherina, Ulrika Marking, Nina Greilert‐Norin, et al.. (2024). Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023. The Lancet Regional Health - Europe. 38. 100872–100872.
7.
Aguilera, Katherina, Ulrika Marking, Nina Greilert‐Norin, et al.. (2024). Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum. Frontiers in Immunology. 15. 1346749–1346749. 11 indexed citations
8.
Chen, Puran, Mikael Åberg, Hans‐Gustaf Ljunggren, et al.. (2023). SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants. Journal of Clinical Immunology. 43(6). 1075–1082. 3 indexed citations
9.
Andersson, Maria, Jinghua Wu, David Wullimann, et al.. (2023). Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia. Journal of Hematology. 12(4). 170–175. 3 indexed citations
10.
Marking, Ulrika, Sebastian Havervall, Nina Greilert‐Norin, et al.. (2023). Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers. Nature Communications. 14(1). 1577–1577. 12 indexed citations
11.
Siegbahn, Agneta, Niclas Eriksson, Erika Assarsson, et al.. (2023). Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21). PLoS ONE. 18(11). e0293465–e0293465. 2 indexed citations
12.
Altamash, Mohammad, et al.. (2022). Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis. Biomedicines. 10(3). 714–714. 11 indexed citations
13.
Zhao, Hongxing, Mengqi Wang, Liza Löf, et al.. (2022). Detection of SARS-CoV-2 antibodies in serum and dried blood spot samples of vaccinated individuals using a sensitive homogeneous proximity extension assay. New Biotechnology. 72. 139–148. 5 indexed citations
14.
Wallentin, Lars, Niclas Eriksson, Tanja B. Grammer, et al.. (2021). Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study. PLoS Medicine. 18(1). e1003513–e1003513. 86 indexed citations
15.
Andersson, Hanna, Tomas Luther, Sten Rubertsson, et al.. (2021). Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients. Cytokine. 146. 155589–155589. 17 indexed citations
16.
Siegbahn, Agneta, Johan Lindbäck, Ziad Hijazi, et al.. (2021). Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation. Journal of Thrombosis and Haemostasis. 19(11). 2726–2737. 10 indexed citations
17.
Åberg, Mikael, et al.. (2013). Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor. Thrombosis and Haemostasis. 111(4). 748–760. 11 indexed citations
18.
Åberg, Mikael & Agneta Siegbahn. (2013). Tissue factor non-coagulant signaling – molecular mechanisms and biological consequences with a focus on cell migration and apoptosis. Journal of Thrombosis and Haemostasis. 11(5). 817–825. 45 indexed citations
19.
Åberg, Mikael, Malin Wickström, & Agneta Siegbahn. (2007). Simvastatin induces apoptosis in human breast cancer cells in a NFκB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa. Thrombosis Research. 122(2). 191–202. 33 indexed citations
20.
Mälarstig, Anders, et al.. (2003). A quantitative real-time PCR method for tissue factor mRNA. Thrombosis Research. 112(3). 175–183. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastiano Cicco Breakdown of academic impact, for papers by Emilie Montenont Breakdown of academic impact, for papers by Michael Bernimoulin Breakdown of academic impact, for papers by Monica D. Traystman Breakdown of academic impact, for papers by Samir Saheb Breakdown of academic impact, for papers by Francisco Vidal Breakdown of academic impact, for papers by Noriyuki Hiramatsu Breakdown of academic impact, for papers by Debjit Biswas Breakdown of academic impact, for papers by Baohua Qian Breakdown of academic impact, for papers by Vesna Brglez
Rankless by CCL
2026